Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

miR-125b develops chemoresistance in Ewing sarcoma/primitive neuroectodermal tumor.

Iida K, Fukushi J, Matsumoto Y, Oda Y, Takahashi Y, Fujiwara T, Fujiwara-Okada Y, Hatano M, Nabashima A, Kamura S, Iwamoto Y.

Cancer Cell Int. 2013 Mar 4;13(1):21. doi: 10.1186/1475-2867-13-21.

2.

MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression.

Zhou M, Liu Z, Zhao Y, Ding Y, Liu H, Xi Y, Xiong W, Li G, Lu J, Fodstad O, Riker AI, Tan M.

J Biol Chem. 2010 Jul 9;285(28):21496-507. doi: 10.1074/jbc.M109.083337. Epub 2010 May 11.

3.

MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf.

Xia HF, He TZ, Liu CM, Cui Y, Song PP, Jin XH, Ma X.

Cell Physiol Biochem. 2009;23(4-6):347-58. doi: 10.1159/000218181. Epub 2009 May 6.

4.

MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets.

Le MT, Xie H, Zhou B, Chia PH, Rizk P, Um M, Udolph G, Yang H, Lim B, Lodish HF.

Mol Cell Biol. 2009 Oct;29(19):5290-305. doi: 10.1128/MCB.01694-08. Epub 2009 Jul 27.

5.

Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.

Guo L, Liu Y, Bai Y, Sun Y, Xiao F, Guo Y.

Eur J Cancer. 2010 Jun;46(9):1692-702. doi: 10.1016/j.ejca.2010.02.043. Epub 2010 Apr 3.

PMID:
20371173
6.

Role of microRNAs in drug-resistant ovarian cancer cells.

Sorrentino A, Liu CG, Addario A, Peschle C, Scambia G, Ferlini C.

Gynecol Oncol. 2008 Dec;111(3):478-86. doi: 10.1016/j.ygyno.2008.08.017. Epub 2008 Sep 26.

PMID:
18823650
7.

miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.

Zhu W, Xu H, Zhu D, Zhi H, Wang T, Wang J, Jiang B, Shu Y, Liu P.

Cancer Chemother Pharmacol. 2012 Mar;69(3):723-31. doi: 10.1007/s00280-011-1752-3. Epub 2011 Oct 13.

PMID:
21993663
8.

MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells.

Husted S, Søkilde R, Rask L, Cirera S, Busk PK, Eriksen J, Litman T.

Mol Pharm. 2011 Dec 5;8(6):2055-62. doi: 10.1021/mp200255d. Epub 2011 Sep 21.

PMID:
21899346
9.

MicroRNA miR-125b induces senescence in human melanoma cells.

Glud M, Manfé V, Biskup E, Holst L, Dirksen AM, Hastrup N, Nielsen FC, Drzewiecki KT, Gniadecki R.

Melanoma Res. 2011 Jun;21(3):253-6. doi: 10.1097/CMR.0b013e328345333b.

PMID:
21460750
10.

Camptothecin induces apoptosis in cancer cells via microRNA-125b-mediated mitochondrial pathways.

Zeng CW, Zhang XJ, Lin KY, Ye H, Feng SY, Zhang H, Chen YQ.

Mol Pharmacol. 2012 Apr;81(4):578-86. doi: 10.1124/mol.111.076794. Epub 2012 Jan 17.

11.

Subsite-based alterations in miR-21, miR-125b, and miR-203 in squamous cell carcinoma of the oral cavity and correlation to important target proteins.

Boldrup L, Coates PJ, Wahlgren M, Laurell G, Nylander K.

J Carcinog. 2012;11:18. doi: 10.4103/1477-3163.104007. Epub 2012 Nov 28.

12.

Enforced expression of miR-125b affects myelopoiesis by targeting multiple signaling pathways.

Surdziel E, Cabanski M, Dallmann I, Lyszkiewicz M, Krueger A, Ganser A, Scherr M, Eder M.

Blood. 2011 Apr 21;117(16):4338-48. doi: 10.1182/blood-2010-06-289058. Epub 2011 Mar 2.

13.

MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia.

Akbari Moqadam F, Lange-Turenhout EA, Ariës IM, Pieters R, den Boer ML.

Leuk Res. 2013 Oct;37(10):1315-21. doi: 10.1016/j.leukres.2013.06.027. Epub 2013 Jul 31.

PMID:
23915977
14.

Characterization of microRNA-125b expression in MCF7 breast cancer cells by ATR-FTIR spectroscopy.

Ozek NS, Tuna S, Erson-Bensan AE, Severcan F.

Analyst. 2010 Dec;135(12):3094-102. doi: 10.1039/c0an00543f. Epub 2010 Oct 26.

PMID:
20978686
15.

miR-125b targets ARID3B in breast cancer cells.

Akhavantabasi S, Sapmaz A, Tuna S, Erson-Bensan AE.

Cell Struct Funct. 2012;37(1):27-38.

16.

miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.

Zhu W, Zhu D, Lu S, Wang T, Wang J, Jiang B, Shu Y, Liu P.

Med Oncol. 2012 Mar;29(1):384-91. doi: 10.1007/s12032-010-9797-4. Epub 2011 Jan 22.

PMID:
21258880
17.
18.

miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation.

Mizuno Y, Yagi K, Tokuzawa Y, Kanesaki-Yatsuka Y, Suda T, Katagiri T, Fukuda T, Maruyama M, Okuda A, Amemiya T, Kondoh Y, Tashiro H, Okazaki Y.

Biochem Biophys Res Commun. 2008 Apr 4;368(2):267-72. doi: 10.1016/j.bbrc.2008.01.073. Epub 2008 Jan 28.

PMID:
18230348
19.

MicroRNA-125b induces cancer cell apoptosis through suppression of Bcl-2 expression.

Zhao A, Zeng Q, Xie X, Zhou J, Yue W, Li Y, Pei X.

J Genet Genomics. 2012 Jan;39(1):29-35. doi: 10.1016/j.jgg.2011.12.003. Epub 2011 Dec 28.

PMID:
22293115
20.

miRNA expression profile during osteogenic differentiation of human adipose-derived stem cells.

Zhang ZJ, Zhang H, Kang Y, Sheng PY, Ma YC, Yang ZB, Zhang ZQ, Fu M, He AS, Liao WM.

J Cell Biochem. 2012 Mar;113(3):888-98.

PMID:
22371969

Supplemental Content

Support Center